It's not every day that the leaders of the two most prominent cardiology and cardiovascular organizations in the United States come from the same hospital.
Mary Walsh is BWH's first patient to undergo a transcatheter aortic valve replacement without general anesthesia.
The Cardio-Oncology Program, a joint collaboration between BWH and Dana-Farber Cancer Institute, focuses on the cardiovascular side effects of cancer therapy while maximizing cardiovascular outcomes for cancer survivors.
A team of researchers has discovered certain proteins in osteoclasts, a precursor to bone, that may be used in helping to destroy cardiovascular calcification by dissolving mineral deposits.
BWH leadership and cardiovascular staff came together Jan. 22 to celebrate the launch of BWH’s Heart & Vascular Center, a fully integrated and aligned service dedicated to delivering life-giving breakthroughs.
An international symposium assembled at BWH to discuss heart disease.
The Center for Advanced Heart Disease at BWH is taking an innovative approach to caring for some of its sickest patients.
The Cardiovascular Inflammation Reduction Trial studies whether a drug used to treat rheumatoid arthritis can also reduce recurrent cardiovascular events.
Richard Blumberg, MD, humbly refers to his hemophilia drug discovery as “a beautiful mistake.”
Fill in your details below or click an icon to log in:
You are commenting using your WordPress.com account. ( Log Out / Change )
You are commenting using your Twitter account. ( Log Out / Change )
You are commenting using your Facebook account. ( Log Out / Change )
You are commenting using your Google+ account. ( Log Out / Change )
Connecting to %s
Notify me of follow-up comments via email.
Basic HTML is allowed. Your email address will not be published.
Subscribe to this comment feed via RSS
Get every new post delivered to your Inbox.